MedTrace Logo

The Finnish Diabetes Prevention Study

NCT00518167 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 522

Last updated 2023-09-14

No results posted yet for this study

Summary

The aim of this study is to clarify whether lifestyle intervention provided to people with high type 2 diabetes risk will lower the cumulative incidence of diabetes. Furthermore, the aim is to study the effect of lifestyle intervention on cardiovascular risk.

Conditions

Interventions

BEHAVIORAL

Intensive lifestyle counselling

Individualized dietary and physical activity counselling aiming at 1. weight reduction 2. dietary fibre 15 g /1000 kcal or more 3. energy proportion of dietary fat less than 30% 4. energy proportion of saturated fat less than 10% 5. moderate physical activity \>30 minutes per day or 4 hours per week

Sponsors & Collaborators

  • University of Eastern Finland

    collaborator OTHER

  • Finnish Diabetes Association

    collaborator OTHER

  • University of Oulu

    collaborator OTHER

  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Jaakko Tuomilehto, professor emeritus · Finnish Institute for Health and Welfare and University of Helsinki

  • Matti Uusitupa, professor emeritus · University of Eastern Finland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1993-11-30
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00518167 on ClinicalTrials.gov